《DORA：在一项从多替格雷韦或依非韦伦到以多拉韦林为基础的一线抗逆转录病毒治疗的iii期ib转换研究中，黑人艾滋病妇女48周体重和代谢变化》的评论。

{"title":"《DORA：在一项从多替格雷韦或依非韦伦到以多拉韦林为基础的一线抗逆转录病毒治疗的iii期ib转换研究中，黑人艾滋病妇女48周体重和代谢变化》的评论。","authors":"Amit Varma, Mahendra Pratap Singh, Sanjit Sah, Amogh Verma","doi":"10.1111/hiv.13755","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":"26 3","pages":"504-506"},"PeriodicalIF":2.8000,"publicationDate":"2024-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Commentary on ‘DORA: 48-week weight and metabolic changes in black women with HIV, in a phase IIIb switch study from dolutegravir- or efavirenz- to doravirine-based first-line antiretroviral therapy’\",\"authors\":\"Amit Varma, Mahendra Pratap Singh, Sanjit Sah, Amogh Verma\",\"doi\":\"10.1111/hiv.13755\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13176,\"journal\":{\"name\":\"HIV Medicine\",\"volume\":\"26 3\",\"pages\":\"504-506\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-12-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/hiv.13755\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hiv.13755","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}